Carr Douglas sold 266 shares of Century Therapeutics, Inc. at $1.52 for −$404 on Nov 3, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SVP Finance & Operations
SVP Finance & Operations
Filed Nov 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$404.05Shares × reported price
Shares traded
266Common Stock
Price per share
$1.52Reported price. Read footnotes for ranges.
% of reported position traded
0.05%This security and ownership context
Holdings after
502,641Direct
Trade date
Nov 3, 2026Sell
Filed
Nov 5, 2026, 4:10 PM ET2-day reporting delay
Accession
0001867173-26-000022Code S · Transaction 393461
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 502,907 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

IPSC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
IPSC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +5.5%1w ago 0%1d ago 0%
Returns since7d +12%30d90d180d1y

Footnotes in full

F1: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.